Core Points - NeuroOne Medical Technologies Corporation will participate in The ThinkEquity Conference on October 30, 2024, in New York, focusing on innovations in surgical care for neurological disorders [1][3] - Ron McClurg, CFO of NeuroOne, will present at 9:00 am ET and the company will conduct one-on-one investor meetings throughout the day [1][2] - The ThinkEquity Conference is a platform for institutional investors and industry professionals, featuring over 70 company presentations and 500+ one-on-one meetings in the past [3] Company Overview - NeuroOne is a developmental stage medical technology company dedicated to minimally invasive and high-definition solutions for EEG recording, brain stimulation, and ablation for neurological disorders [3] - The company aims to improve patient outcomes and reduce procedural costs for conditions such as epilepsy, Parkinson's disease, and chronic pain, with potential applications in depression and artificial intelligence [3]
NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference